DIFFERENCES BETWEEN PLASMA AND SERUM COMPLEMENT IN PATIENTS WITH CHRONIC LIVER-DISEASE
- 1 January 1976
- journal article
- research article
- Vol. 25 (3) , 403-409
Abstract
Of 60 patients with chronic liver disease, 8 with cirrhosis or chronic hepatitis had very low serum CH50 [total hemolytic complement (C)] but normal plasma CH50. The C component profiles of these sera revealed markedly decreased C4 [the 4th C component] and C2 activities and normal C3T (C3-C9) activities. The early C components probably were nonspecifically activated during blood coagulation in these patients. No difference between plasma and serum CH50 was found in patients with hepatitis B(s [surface]) antigen.This publication has 26 references indexed in Scilit:
- A new method for the preparation of EAC14 cell with human or guinea-pig serumJournal of Immunological Methods, 1974
- The Inactivator of the First Component of Human Complement (C1INA)International Archives of Allergy and Immunology, 1974
- Complement and liver cell function in 53 patients with liver diseaseThe American Journal of Medicine, 1973
- Ontogeny of the Human Complement System: In Vitro Biosynthesis of Individual Complement Components by Fetal TissuesJournal of Clinical Investigation, 1972
- The Pathogenesis of Arthritis Associated with Viral HepatitisNew England Journal of Medicine, 1971
- RELATIONSHIP OF HEPATITIS-ASSOCIATED ANTIGEN (H.A.A.) TO ACUTE AND CHRONIC LIVER INJURYThe Lancet, 1971
- The serum concentration of the third component of complement 1C/ 1A in liver diseaseGut, 1971
- Detection of Australia Antigen by Means of Immune Adherence Haemagglutination TestVox Sanguinis, 1971
- Hemagglutination Assay for Antigen and Antibody Associated with Viral HepatitisScience, 1970
- Human C′3: Evidence for the Liver as the Primary Site of SynthesisScience, 1969